Companies / Arcus Biosciences, Inc. / Activity
Activity — Arcus Biosciences, Inc.
28 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Jaen Juan C. Executive | Sell | Common Stock | $633.2K | -30K -3.11% | 924,393 0.73% of shares | medium |
| Dec 31, 2025 | Goeltz II Robert C. Executive | Sell | Common Stock | $153.2K | -7K -8.80% | 67,924 0.05% of shares | medium |
| Jan 5, 2026 | Jaen Juan C. Executive | Sell | Common Stock | $45.9K | -2K -0.22% | 922,340 0.72% of shares | low |
| Jan 5, 2026 | Jaen Juan C. Executive | Sell | Common Stock | $2.3K | -100 -0.01% | 922,240 0.72% of shares | low |
| Jun 11, 2026 | Machado Patrick Director | Grant | Common Stock | $0 | +6K +14.77% | 44,300 0.03% of shares | low |
| Jun 11, 2026 | Kaneko Yasunori Director | Grant | Common Stock | $0 | +6K +28.50% | 25,700 0.02% of shares | low |
| Jun 11, 2026 | Falberg Kathryn E Director | Grant | Common Stock | $0 | +6K +14.77% | 44,300 0.03% of shares | low |
| Jun 11, 2026 | Perlman Andrew J Director | Grant | Common Stock | $0 | +6K +13.37% | 48,325 0.04% of shares | low |
| Jan 23, 2026 | Tang Carolyn C. Executive | Grant | Common Stock | $0 | +24K +19.24% | 148,734 0.12% of shares | low |
| Jan 23, 2026 | Azoy Alexander Executive | Grant | Common Stock | $0 | +21K +113.59% | 39,581 0.03% of shares | low |
| Jan 23, 2026 | Markus Richard Executive | Grant | Common Stock | $0 | +24K +36.56% | 89,647 0.07% of shares | low |
| Jan 23, 2026 | Jarrett Jennifer Executive | Grant | Common Stock | $0 | +31K +16.06% | 224,024 0.18% of shares | low |
| Jan 23, 2026 | Goeltz II Robert C. Executive | Grant | Common Stock | $0 | +24K +35.33% | 91,924 0.07% of shares | low |
| Jan 23, 2026 | Jaen Juan C. Executive | Grant | Common Stock | $0 | +31K +8.96% | 377,012 0.30% of shares | low |
| Jan 23, 2026 | Rosen Terry J CEO | Grant | Common Stock | $0 | +79K +3.66% | 2,236,409 1.76% of shares | low |
| Jan 8, 2026 | Rosen Terry J CEO | Gift | Common Stock | $0 | -35K -1.60% | 2,157,409 1.69% of shares | low |
| Dec 30, 2025 | Rosen Terry J CEO | Gift | Common Stock | $0 | -2K -0.11% | 2,192,409 1.72% of shares | low |
| Jun 11, 2026 | Machado Patrick Director | Grant | Stock Option (Right to Buy) | — | +17K | 16,900 0.01% of shares | low |
| Jun 11, 2026 | Kaneko Yasunori Director | Grant | Stock Option (Right to Buy) | — | +17K | 16,900 0.01% of shares | low |
| Jun 11, 2026 | Falberg Kathryn E Director | Grant | Stock Option (Right to Buy) | — | +17K | 16,900 0.01% of shares | low |
| Jun 11, 2026 | Perlman Andrew J Director | Grant | Stock Option (Right to Buy) | — | +17K | 16,900 0.01% of shares | low |
| Jan 23, 2026 | Tang Carolyn C. Executive | Grant | Stock Option (right to buy) | — | +96K | 96,000 0.08% of shares | low |
| Jan 23, 2026 | Azoy Alexander Executive | Grant | Stock Option (right to buy) | — | +14K | 14,050 0.01% of shares | low |
| Jan 23, 2026 | Markus Richard Executive | Grant | Stock Option (right to buy) | — | +96K | 96,000 0.08% of shares | low |
| Jan 23, 2026 | Jarrett Jennifer Executive | Grant | Stock Option (right to buy) | — | +126K | 126,000 0.10% of shares | low |
| Jan 23, 2026 | Goeltz II Robert C. Executive | Grant | Stock Option (right to buy) | — | +96K | 96,000 0.08% of shares | low |
| Jan 23, 2026 | Jaen Juan C. Executive | Grant | Stock Option (right to buy) | — | +126K | 126,000 0.10% of shares | low |
| Jan 23, 2026 | Rosen Terry J CEO | Grant | Stock Option (right to buy) | — | +315K | 315,000 0.25% of shares | low |